Compare KRP & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KRP | NEOG |
|---|---|---|
| Founded | 2013 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2017 | 1989 |
| Metric | KRP | NEOG |
|---|---|---|
| Price | $11.55 | $7.13 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $17.50 | $8.83 |
| AVG Volume (30 Days) | 789.2K | ★ 4.1M |
| Earning Date | 11-06-2025 | 01-08-2026 |
| Dividend Yield | ★ 14.88% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $315,520,668.00 | ★ $886,886,000.00 |
| Revenue This Year | $7.04 | N/A |
| Revenue Next Year | $0.92 | $1.80 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.98 | $3.87 |
| 52 Week High | $16.59 | $13.41 |
| Indicator | KRP | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 31.42 | 63.81 |
| Support Level | $11.31 | $6.99 |
| Resistance Level | $11.59 | $7.53 |
| Average True Range (ATR) | 0.26 | 0.31 |
| MACD | -0.05 | 0.05 |
| Stochastic Oscillator | 13.29 | 76.05 |
Kimbell Royalty Partners LP owns and acquires mineral and royalty interests in oil and natural gas properties throughout the United States. The company's basins and producing regions include areas of interest in the Permian Basin, Mid-Continent, Terryville/Cotton Valley/Haynesville, Appalachian Basin, Eagle Ford, Bakken/Williston Basin, and DJ Basin/Rockies/Niobrara. Its revenues are derived from royalty payments received from operators based on the sale of oil, natural gas and NGL production, as well as the sale of NGLs that are extracted from natural gas during processing.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.